WARNING: This product contains nicotine.
Nicotine is an addictive chemical.


SMOOD is committed to regulatory compliance.

The PMTA, also known as the Premarket Tobacco Product Application, is required by the FDA for tobacco-derived, and non-tobacco nicotine products.  The purpose of this application is to demonstrate scientifically that nicotine containing products are appropriate for protection of public health (APPH). 

A Premarket Tobacco Product Application (PMTA) must be submitted for any new tobacco product seeking an FDA marketing order, under section 910(b) of the Federal Food, Drug, and Cosmetic (FD&C) Act. A PMTA must provide scientific data that demonstrates a product is appropriate for the protection of public health. In order to reach such a decision and to authorize marketing, FDA considers (per section 910(c)(4)), among other things: 

  • Risks and benefits to the population as a whole, including people who would use the proposed new tobacco product as well as nonusers;
  • Whether adults who currently use any tobacco product would be more or less likely to stop using such products if the proposed new tobacco product were available; and
  • Whether people who currently do not use any tobacco products would be more or less likely to begin using tobacco products if the new product were available 


Information provided by SMOOD to the FDA for review includes:

  • Full reports of all information published or known to, or which should reasonably be known to, the applicant concerning investigations which have been made to show the health risks of such tobacco product and whether such tobacco product presents less risk than other tobacco products.
  • Full statement of the components, ingredients, additives, and properties, and of the principle or principles of operation.
  • Full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and when relevant, packing and installation.
  • An identifying reference to any tobacco product standard, if applicable. If so, either:
    • Adequate information to show that such aspect of such tobacco product fully meets such tobacco product standard, or
    • Adequate information to justify any deviation from such standard
  • Samples of the tobacco product as required
  • Specimens of proposed labeling

The FDA has interpreted these statutory requirements in the PMTA Final Rule, under which a PMTA must contain the following sections (per 21 CFR 1114.7):

  • General information  
  • Descriptive information  
  • Product samples  
  • Labeling and description of marketing plans 
  • Statement of compliance with 21 CFR part 25  
  • Summary  
  • Product formulation  
  • Manufacturing  
  • Health risk investigations  
  • The effect on the population as a whole  
  • Certification statement

The review of the PMTA is a rigorous, four-phase process that thoroughly examines the lifecycle of products to ensure products are safely manufactured and sold.